See more : Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) Income Statement Analysis – Financial Results
Complete financial analysis of Mandarake Inc. (2652.T) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Mandarake Inc., a leading company in the Specialty Retail industry within the Consumer Cyclical sector.
- Lotus Bio-Technology Development Corp. (LBTD) Income Statement Analysis – Financial Results
- Beat Holdings Limited (9399.T) Income Statement Analysis – Financial Results
- Aarti Drugs Limited (AARTIDRUGS.BO) Income Statement Analysis – Financial Results
- King Polytechnic Engineering Co., Ltd. (6122.TWO) Income Statement Analysis – Financial Results
- GoPro, Inc. (GPRO.SW) Income Statement Analysis – Financial Results
Mandarake Inc. (2652.T)
About Mandarake Inc.
Mandarake Inc. operates and manages old books and antique stores in Japan. It provides newest to vintage items, including, toys, dolls, games, subcultures, art books, doujinshi, etc. It also edits and sells publications. The company sells its products through stores, as well as online. Mandarake Inc. was founded in 1980 and is headquartered in Tokyo, Japan.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 12.84B | 10.59B | 9.63B | 9.02B | 10.06B |
| Cost of Revenue | 5.82B | 4.81B | 4.37B | 4.24B | 4.87B |
| Gross Profit | 7.02B | 5.78B | 5.26B | 4.78B | 5.19B |
| Gross Profit Ratio | 54.69% | 54.58% | 54.64% | 52.99% | 51.57% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 104.41M | 90.44M | 92.37M | 88.57M | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 104.41M | 90.44M | 92.37M | 88.57M | 4.13B |
| Other Expenses | 5.04B | 5.26M | 4.31M | 12.76M | -163.29M |
| Operating Expenses | 5.15B | 4.84B | 4.66B | 4.52B | 4.30B |
| Cost & Expenses | 10.97B | 9.65B | 9.03B | 8.76B | 9.17B |
| Interest Income | 6.00K | 5.00K | 7.00K | 4.00K | 4.00K |
| Interest Expense | 34.47M | 36.95M | 40.29M | 45.85M | 46.09M |
| Depreciation & Amortization | 218.21M | 238.66M | 235.77M | 243.09M | 252.26M |
| EBITDA | 2.11B | 1.18B | 840.85M | 535.29M | 1.15B |
| EBITDA Ratio | 16.40% | 11.15% | 8.73% | 5.68% | 11.37% |
| Operating Income | 1.87B | 934.07M | 600.51M | 257.27M | 890.95M |
| Operating Income Ratio | 14.60% | 8.82% | 6.24% | 2.85% | 8.86% |
| Total Other Income/Expenses | -21.40M | -29.49M | -35.72M | -11.45M | -43.43M |
| Income Before Tax | 1.85B | 904.58M | 564.79M | 245.83M | 847.52M |
| Income Before Tax Ratio | 14.43% | 8.54% | 5.87% | 2.73% | 8.43% |
| Income Tax Expense | 604.28M | 317.10M | 207.40M | 106.63M | 283.48M |
| Net Income | 1.25B | 587.48M | 357.39M | 139.19M | 564.03M |
| Net Income Ratio | 9.72% | 5.55% | 3.71% | 1.54% | 5.61% |
| EPS | 37.69 | 17.74 | 10.79 | 4.20 | 17.03 |
| EPS Diluted | 37.69 | 17.74 | 10.79 | 4.20 | 17.03 |
| Weighted Avg Shares Out | 33.12M | 33.12M | 33.12M | 33.12M | 33.12M |
| Weighted Avg Shares Out (Dil) | 33.12M | 33.12M | 33.12M | 33.12M | 33.12M |
Source: https://incomestatements.info
Category: Stock Reports